Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial

American Journal of Hypertension

Volumn 23, Issue 9, 2010, Pages 1023-1030

  Gupta, Ajay K ^a   Poulter, Neil R ^a   Dobson, Joanna ^a   Eldridge, Sandra ^b   Cappuccio, Francesco P ^c   Caulfield, Mark ^b   Collier, David ^b   Cruickshank, J Kennedy ^d   Sever, Peter S ^a   Feder, Gene ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

antihypertensive agents; blood pressure; ethnicity; hypertension; race; treatment

Indexed keywords

AMLODIPINE; ATENOLOL; BENDROFLUMETHIAZIDE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGE FACTORS; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTINENTAL POPULATION GROUPS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PERINDOPRIL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; TREATMENT OUTCOME;

EID: 77955934947     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.105     Document Type: Article

References (23)

1. Seedat YK, Parag KB. A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension. S Afr Med J 1987; 71: 149-153.
2. Holland OB, Gomez-Sanchez CE, Kuhnert LV, Poindexter C, Pak CY. Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients. Arch Intern Med 1979; 139:1015-1021.
3. Cruickshank JK, Anderson NM, Wadsworth J, Young SM, Jepson E. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol. BMJ 1988; 297:1155-1159.
4. Materson BJ. Black/white differences in response to antihypertensive therapy. J Natl Med Assoc 1985; 77(Suppl):9-13.
5. Materson BJ, Reda DJ, Cushman WC. Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. A m J Hypertens 1995; 8:189-192.
6. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328:914-921.
7. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA 1998; 280:1168-1172.
8. Weir MR, Chrysant SG, McCarron DA, Canossa-Terris M, Cohen JD, Gunter PA, Lewin AJ, Mennella RF, Kirkegaard LW, Hamilton JH, Weinberger MH, Weder AB. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension 1998; 31:1088-1096.
9. Nguyen T T, Kaufman JS, Whitsel EA, Cooper RS. Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis. Am J Hypertens 2009; 22:911-917.
10. Oparil S. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications. Hypertension 2003; 41:1006-1009.
11. Furberg CD, Wright JT, Davis BR, Cutler JA, Alderman M, Black H, Cushman W, Grimm R, Haywood LJ, Leenen F, Oparil S, Probstfield J, Whelton P, Nwachuku C, Gordon D, Proschan M, Einhorn P, Ford CE, Piller LB, Dunn JK, Goff D, Pressel S, Bettencourt J, deLeon B, Simpson LM, Blanton J, Geraci T, Walsh SM, Nelson C, Rahman M, Juratovac A, Pospisil R, Carroll L, Sullivan S, Russo J, Barone G, Christian R, Feldman S, Lucente T, Calhoun D, Jenkins K, McDowell P, Johnson J, Kingry C, Alzate J, Margolis KL, Holland-Klemme LA, Jaeger B, Williamson J, Louis G, Ragusa P, Williard A, Ferguson RLS, Tanner J, Eckfeldt J, Crow R, Pelosi J. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
12. Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med 2004; 141:614-627.
13. National Collaborating Centre for Chronic Conditions, British Hypertension Society. Hypertension: Management of Hypertension in Adults in Primary Care. NICE Clinical Guideline 34 (Update). London, 2006.
14. Kirby PL, Caulfield MC, Collier DJ, Eldridge S, Griffiths CG, Hemingway H, Poulter NR, Feder GS; Anglo-Scandinavian Cardiac Outcomes Trial. Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group. J Hum Hypertens 2001; 15(Suppl 1):S61-S64.
15. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906.
16. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart 2003; 89:681-686.
17. Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation 2006; 113:e924-e929.
18. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
19. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 World Health Organization- International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21:1009-1060.
20. Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P. Involving South Asian patients in clinical trials. Health Technol Assess 2004;8:iii, 1-iii109.
21. Bradby H. Describing ethnicity in health research. Ethn Health 2003; 8:5-13.
22. Chobanian AV. Effects of beta blockers and other antihypertensive drugs on cardiovascular risk. Am J Cardiol 1987; 59:48F-52F.
23. Bhopal R, Sengupta-Wiebe S. Cardiovascular risks and outcomes: ethnic variations in hypertensive patients. Heart 2000; 83:495-496.